In this video, John C. Byrd, MD, a professor at The Ohio State University, discussed a pair of abstracts that looked at the use of ponatinib for Philadelphia chromosome positive ALL and resistant CML.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback